ClinicalTrials.Veeva

Menu

Unmasking Right Ventricular and Pulmonary Derangements With Exercise and Oxygen in Early Stage Cardiopulmonary Diseases

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Cardiopulmonary Disease

Treatments

Other: Echocardiography
Other: Pulmonary Gas Exchange

Study type

Interventional

Funder types

Other

Identifiers

NCT03911856
19-000626

Details and patient eligibility

About

Researchers are trying to develop innovative strategies that target the early identification heart and lung imbalances in patients with cardiopulmonary diseases.

Enrollment

7 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy controls (no known cardiac or pulmonary disease);
  • PAH/HFpEF patients with known RV failure;
  • PAH/HFpEF patients with known pulmonary failure
  • Newly diagnosed PAH/HFpEF patients without any evidence of profound RV or pulmonary dysfunction.

Exclusion criteria

  • Persons unable to perform light exercise
  • Persons pregnant or planning to be pregnant

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

7 participants in 2 patient groups

Non-invasive assesment techniques
Experimental group
Description:
We hypothesize that non-invasive indices of right ventricular RV (echocardiograph-derived strain and strain rate) and pulmonary (gas exchange-derived lung diffusion and surface area) function during light exercise will successfully identify and discern patients with known RV dysfunction pulmonary arterial hypertension and heart failure with preserved ejection fraction(PAH/HFpEF with RV failure) from those with known pulmonary dysfunction (PAH/HFpEF with pulmonary fibrosis). Additionally, we hypothesize that our assessment techniques will identify subtle derangements in RV and pulmonary function in newly diagnosed PAH and HFpEF patients, and that this may guide early and targeted therapeutic intervention.
Treatment:
Other: Echocardiography
Other: Pulmonary Gas Exchange
Efficacy of acute-oxygen therapy during exercise
Experimental group
Description:
We hypothesize that breathing hyperoxia will increase exercise capacity by reversing RV and pulmonary derangements, and that the mechanisms of action will be related to the underlying dysfunction (e.g., reducing pulse volume recording PVR, increasing RV functional reserve, increasing gas diffusion).
Treatment:
Other: Echocardiography
Other: Pulmonary Gas Exchange

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems